Cited by 304Histone Deacetylase Inhibitors ResearchGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.

The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts

Kelly, Richard D.W., Cowley, Shaun M.·2013·Biochemical Society Transactions

DOI 10.1042/bst20130010

Open this paper in CoChat — free account

Abstract

HDACs (histone deacetylases) 1 and 2 are ubiquitous long-lived proteins, which are often found together in three major multiprotein co-repressor complexes: Sin3, NuRD (nucleosome remodelling and deacetylation) and CoREST (co-repressor for element-1-silencing transcription factor). Although there is a burgeoning number of non-histone proteins within the acetylome, these complexes contain multiple DNA/chromatin-recognition motifs, which, in combination with transcription factors, target HDAC1/2 to chromatin. Their physiological roles should therefore be viewed within the framework of chromatin manipulation. Classically, HDACs were thought to be recruited predominantly by transcriptional repressors to facilitate local histone deacetylation and transcriptional repression. More recently, genome-wide assays have mapped HDAC1/2 and their associated proteins to transcriptionally active loci and have provided alternative context-specific functions, whereby their repressive functions are subtly exerted to balance transcriptional activation and repression. With a few significant exceptions (early embryogenesis, brain development), HDAC1 and HDAC2 are functionally redundant. In most mouse knockout studies, deletion of both enzymes is required in order to produce a substantial phenotype. HDAC1/2 activity has been implicated in the development of numerous tissue and cell types, including heart, skin, brain, B-cells and T-cells. A common feature in all HDAC1/2-knockout, -knockdown and small-molecule inhibitor studies is a reduction in cell proliferation. A generic role in cell cycle progression could be exploited in cancer cells, by blocking HDAC1/2 activity with small-molecule inhibitors, making them potentially useful drug targets.

Integrity signals

Registry

Crossref · 10.1042/bst20130010

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R. D., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,788
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Haberland, M., Montgomery, R. L., & Olson, E. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,600
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Structure and ligand of a histone acetyltransferase bromodomain
Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732
HDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,506
Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes
Wang, Z., Zang, C., Cui, K., Schones, D. E., Barski, A., Peng, W., & Zhao, K. (2009) · Cell · doi:10.1016/j.cell.2009.06.049 · Cited by 1,344
Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic Transcription
Carrozza, M. J., Li, B., Florens, L. A., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W.-J., Anderson, S., Yates, J. R., Washburn, M. P., et al. (2005) · Cell · doi:10.1016/j.cell.2005.10.023 · Cited by 1,338

Show all 71 references

Sorted by citations

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Ho, T. C. S., Chan, A. H. Y., & Ganesan, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00830 · Cited by 795
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Bondarev, A. D., Attwood, M. M., Jonsson, J., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14889 · Cited by 451
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E. M., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 375
Chromatin repressive complexes in stem cells, development, and cancer
Laugesen, A., & Helin, K. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.006 · Cited by 352
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow
Johnson, R. W., Finger, E. C., Olcina, M. M., Vilalta, M., Aguilera, T. A., Miao, Y. R., Merkel, A. R., Johnson, J., Sterling, J. A. R., Wu, J. Y., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3408 · Cited by 266
Common stemness regulators of embryonic and cancer stem cells
Hadjimichael, C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i9.1150 · Cited by 256
The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives
Huwiler, A., & Zangemeister‐Wittke, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.001 · Cited by 227
The nucleosome remodeling and deacetylase complex in development and disease
Basta, J., & Rauchman, M. (2015) · Translational Research · doi:10.1016/j.trsl.2014.05.003 · Cited by 191
Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells
Jamaladdin, S., Kelly, R. D., O’Regan, L., Dovey, O. M., Hodson, G. E., Millard, C. J., Portolano, N., Fry, A. M., Schwabe, J. W. R., & Cowley, S. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321330111 · Cited by 164
Self-citation
Epigenetics Control Microglia Plasticity
Cheray, M., & Joseph, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00243 · Cited by 157
Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications
Cadet, J. L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9040-y · Cited by 169
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Verza, F. A., Das, U., Fachin, A. L., Dimmock, J. R., & Marins, M. (2020) · Cancers · doi:10.3390/cancers12061664 · Cited by 149
Histone deacetylase function in CD4+ T cells
Ellmeier, W., & Seiser, C. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0037-z · Cited by 146
The structure of the core NuRD repression complex provides insights into its interaction with chromatin
Millard, C. J., Varma, N., Saleh, A., Morris, K. L., Watson, P. J., Bottrill, A. R., Fairall, L., Smith, C. J., & Schwabe, J. W. R. (2016) · eLife · doi:10.7554/elife.13941 · Cited by 146
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
Kelly, R. D. W., Chandru, A., Watson, P. J., Song, Y., Blades, M., Robertson, N. S., Jamieson, A. G., Schwabe, J. W. R., & Cowley, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32927-9 · Cited by 138
Self-citation
Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex
Adams, G. E., Chandru, A., & Cowley, S. M. (2018) · Biochemical Journal · doi:10.1042/bcj20170314 · Cited by 131
Self-citation
The application of histone deacetylases inhibitors in glioblastoma
Chen, R., Zhang, M., Zhou, Y., Guo, W., Yi, M., Zhang, Z., Ding, Y., & Wang, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01643-6 · Cited by 127
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes
Smalley, J. P., Adams, G. E., Millard, C. J., Song, Y., Norris, J. K. S., Schwabe, J. W. R., Cowley, S. M., & Hodgkinson, J. T. (2020) · Chemical Communications · doi:10.1039/d0cc01485k · Cited by 121
Self-citation
Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases
Felice, C., Lewis, A., Armuzzi, A., Lindsay, J., & Silver, A. R. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13008 · Cited by 120
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
Thakur, A., Faujdar, C., Sharma, R., Sharma, S., Malik, B., Nepali, K., & Liou, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01946 · Cited by 122
Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation
Li, F., Wu, R., Cui, X., Zha, L., Yu, L., Shi, H., & Xue, B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677930 · Cited by 119
Playing TETris with DNA modifications
Delatte, B., Deplus, R., & Fuks, F. (2014) · The EMBO Journal · doi:10.15252/embj.201488290 · Cited by 118
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
McIntyre, R. L., Daniels, E. G., Molenaars, M., Houtkooper, R. H., & Janssens, G. E. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809854 · Cited by 115
Epigenomes as therapeutic targets
Hamm, C. A., & Costa, F. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.003 · Cited by 114
Epigenetic influence of environmentally neurotoxic metals
Ijomone, O. M., Ijomone, O. K., Iroegbu, J. D., Ifenatuoha, C. W., Olung, N. F., & Aschner, M. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.08.005 · Cited by 99
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
Gameiro, S. R., Malamas, A. S., Tsang, K. Y., Ferrone, S., & Hodge, J. W. (2016) · Oncotarget · doi:10.18632/oncotarget.7180 · Cited by 108
An evolving understanding of nuclear receptor coregulator proteins
Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0227 · Cited by 111
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Mishra, A., Perle, K. L., Kwiatkowski, S., Sullivan, L. A., Sams, G. H., Johns, J., Curphey, D. P., Wen, J., McConnell, K. K., Qi, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1297 · Cited by 105
Transcription and beyond: the role of mammalian class I lysine deacetylases
Moser, M., Hagelkrüys, A., & Seiser, C. (2013) · Chromosoma · doi:10.1007/s00412-013-0441-x · Cited by 99
Spurious transcription factor binding: Non‐functional or genetically redundant?
Spivakov, M. (2014) · BioEssays · doi:10.1002/bies.201400036 · Cited by 96
HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation
Ma, P., & Schultz, R. M. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.31 · Cited by 95
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
He, X., Hui, Z., Xu, L., Bai, R., Gao, Y., Wang, Z., Xie, T., & Ye, X.-Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113946 · Cited by 89
Fetal iron deficiency induces chromatin remodeling at the Bdnf locus in adult rat hippocampus
Tran, P. V., Kennedy, B. C., Lien, Y., Simmons, R. A., & Georgieff, M. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00429.2014 · Cited by 90
Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
Halsall, J. A., & Turner, B. M. (2016) · BioEssays · doi:10.1002/bies.201600070 · Cited by 87
Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8
Ko, S., Russell, J. O., Tian, J., Gao, C., Kobayashi, M., Feng, R., Yuan, X., Shao, C., Ding, H., Poddar, M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.039 · Cited by 87
Diverse Activities of Histone Acylations Connect Metabolism to Chromatin Function
Dutta, A., Abmayr, S. M., & Workman, J. L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.038 · Cited by 87
Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
Wagner, T., Brand, P., Heinzel, T., & Krämer, O. H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.010 · Cited by 85
Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.
Lee, P., Murphy, B., Miller, R., Menon, V., Banik, N. L., Giglio, P., Lindhorst, S., Varma, A. K., Vandergrift, W. A., Patel, S. J., et al. (2015) · PubMed · Cited by 83
Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance
Bahl, S., & Seto, E. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03599-4 · Cited by 82
The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
Cosenza, M., & Pozzi, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082337 · Cited by 84
HDAC1: an environmental sensor regulating endothelial function
Dunaway, L. S., & Pollock, J. S. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab198 · Cited by 82
Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis
Cantley, M. D., Fairlie, D. P., Bartold, P. M., Marino, V., Gupta, P. K., & Haynes, D. R. (2015) · Rheumatology · doi:10.1093/rheumatology/kev022 · Cited by 83
Transcriptional and Epigenetic Substrates of Methamphetamine Addiction and Withdrawal: Evidence from a Long-Access Self-Administration Model in the Rat
Cadet, J. L., Brannock, C., Jayanthi, S., & Krasnova, I. N. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8776-8 · Cited by 78
Histone Deacetylase Inhibitors and Diabetic Kidney Disease
Hadden, M. J., & Advani, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092630 · Cited by 79
Transcriptional and chromatin regulation in interferon and innate antiviral gene expression
Au-Yeung, N., & Horvath, C. M. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.003 · Cited by 74
H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
Hałasa, M., Wawruszak, A., Przybyszewska-Podstawka, A., Jaruga, A., Guz, M., Kałafut, J., Stepulak, A., & Cybulski, M. (2019) · Cells · doi:10.3390/cells8050485 · Cited by 79
lncRNA-Induced Nucleosome Repositioning Reinforces Transcriptional Repression of rRNA Genes upon Hypotonic Stress
Zhao, Z., Dammert, M. A., Grummt, I., & Bierhoff, H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.073 · Cited by 73
The Nucleosome Remodeling and Deacetylase Complex NuRD Is Built from Preformed Catalytically Active Sub-modules
Zhang, W., Aubert, A., de Segura, J. M. G., Karuppasamy, M., Basu, S., Murthy, A. S., Diamante, A., Drury, T. A., Balmer, J., Cramard, J., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.04.025 · Cited by 77
Diverse nucleosome Site-Selectivity among histone deacetylase complexes
Wang, Z. A., Millard, C. J., Lin, C., Gurnett, J. E., Wu, M., Lee, K., Fairall, L., Schwabe, J. W. R., & Cole, P. A. (2020) · eLife · doi:10.7554/elife.57663 · Cited by 72
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Curcio, A., Rocca, R., Alcaro, S., & Artese, A. (2024) · Pharmaceuticals · doi:10.3390/ph17050620 · Cited by 72
Histone deacetylase complexes: Structure, regulation and function
Asmamaw, M. D., He, A., Zhang, L., Liu, H., & Gao, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189150 · Cited by 70
Epigenetic control of transcriptional regulation in pluripotency and early differentiation
Gökbuget, D., & Blelloch, R. H. (2019) · Development · doi:10.1242/dev.164772 · Cited by 73
Characterization of Histone Deacetylase Mechanisms in Cancer Development
Hai, R., He, L., Shu, G., & Yin, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700947 · Cited by 69
Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism
Durham, B. S., Grigg, R., & Wood, I. C. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14144 · Cited by 67
The Role of Histone Protein Acetylation in Regulating Endothelial Function
Fang, Z. H., Wang, X., Sun, X., Hu, W., & Miao, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.672447 · Cited by 66
SOX9 modulates the expression of key transcription factors required for heart valve development
Garside, V. C., Cullum, R., Alder, O., Lu, D. Y., Vander Werff, R., Bilenky, M., Zhao, Y., Jones, S. J. M., Marra, M. A., Underhill, T. M., et al. (2015) · Development · doi:10.1242/dev.125252 · Cited by 65
Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms
Pinkerneil, M., Hoffmann, M. J., Deenen, R., Köhrer, K., Arent, T., Schulz, W. A., & Niegisch, G. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0618 · Cited by 62
Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment
Pan, D., Yang, Q., Fu, X., Shan, S., Zhu, J.-Z., Zhang, K., Li, Z., Ning, Z., & Lu, X. (2014) · MedChemComm · doi:10.1039/c4md00350k · Cited by 61
Histone deacetylases (HDAC) in physiological and pathological bone remodelling
Cantley, M. D., Zannettino, A. C. W., Bartold, P. M., Fairlie, D. P., & Haynes, D. R. (2016) · Bone · doi:10.1016/j.bone.2016.11.028 · Cited by 63
NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency
Marques, J. G., Gryder, B. E., Pavlovic, B., Chung, Y., Ngo, Q. A., Frommelt, F., Gstaiger, M., Song, Y., Benischke, K., Laubscher, D., et al. (2020) · eLife · doi:10.7554/elife.54993 · Cited by 59
KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress
Lezina, L., Aksenova, V., Ivanova, T., Purmessur, N. S., Antonov, A. V., Tentler, D., Fedorova, O., Garabadgiu, A. V., Talianidis, I., Melino, G., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.108 · Cited by 58
The deubiquitinase USP38 promotes NHEJ repair through regulation of HDAC1 activity and regulates cancer cell response to genotoxic insults
Yang, Y., Yang, C., Li, T., Yu, S., Gan, T., Hu, J., Cui, J., & Zheng, X. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2149 · Cited by 57
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
Haydn, T., Metzger, E., Schüle, R., & Fulda, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.239 · Cited by 59
Hypoxia and Chromatin: A Focus on Transcriptional Repression Mechanisms
Batie, M., del Peso, L., & Rocha, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020047 · Cited by 61
The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization
Zheng, X., Sarode, P., Weigert, A., Turkowski, K., Chelladurai, P., Günther, S., Kuenne, C. T., Winter, H., Stenzinger, A., Reu, S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1270 · Cited by 56
Histone deacetylases and atherosclerosis
Zheng, X., Zhou, T., Wang, X., Tong, X.-H., & Ding, J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.048 · Cited by 56
HDAC6 modulates myofibril stiffness and diastolic function of the heart
Lin, Y., Major, J. L., Liebner, T., Hourani, Z., Travers, J. G., Wennersten, S. A., Haefner, K. R., Cavasin, M. A., Wilson, C. E., Jeong, M. Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148333 · Cited by 55
Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway
Zhong, S., Zhao, L., Wang, Y., Zhang, C., Liu, J., Wang, P., Zhou, W., Yang, P., Varghese, Z., Moorhead, J. F., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6808 · Cited by 54
Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles
Liu, H., Chen, S., Yao, X., Li, Y., Chen, C., Liu, J., Saifudeen, Z. R., & El-Dahr, S. S. (2018) · Development · doi:10.1242/dev.153619 · Cited by 57
YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis
Wu, Z., Su, J., Li, F.-L., Chen, T., Mayner, J., Engler, A. J., Ma, S., Li, Q., & Guan, K. (2023) · Nature Communications · doi:10.1038/s41467-023-41585-z · Cited by 52
Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins
Knyphausen, P., de Boor, S., Kuhlmann, N., Scislowski, L., Extra, A., Baldus, L., Schacherl, M., Baumann, U., Neundorf, I., & Lammers, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.726307 · Cited by 52
The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis
Turgeon, N., Gagné, J. M., Blais, M., Gendron, F., Boudreau, F., & Asselin, C. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00393.2013 · Cited by 51
Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
Zhang, S., Duan, S., Xie, Z., Bao, W., Xu, B., Yang, W., & Zhou, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924817 · Cited by 50
Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response
Halsall, J. A., Turan, N., Wiersma, M., & Turner, B. M. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0021-9 · Cited by 50
HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications
Bayat, S., Khaniani, M. S., Choupani, J., Alivand, M. R., & Derakhshan, S. M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.065 · Cited by 51
PWWP2A binds distinct chromatin moieties and interacts with an MTA1-specific core NuRD complex
Link, S., Spitzer, R. M. M., Sana, M., Torrado, M., Völker-Albert, M. C., Keilhauer, E. C., Burgold, T., Pünzeler, S., Low, J. K. K., Lindström, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06665-5 · Cited by 53
Physical and functional interaction between SET1/COMPASS complex component CFP-1 and a Sin3S HDAC complex in C. elegans
Beurton, F., Stempor, P., Caron, M. J., Appert, A., Yan, D., Chen, R. A.-J., Cluet, D., Couté, Y., Herbette, M., Huang, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz880 · Cited by 52
Non-sirtuin histone deacetylases in the control of cardiac aging
Ferguson, B. S., & McKinsey, T. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.03.010 · Cited by 49
Fam60a defines a variant Sin3a‐Hdac complex in embryonic stem cells required for self‐renewal
Streubel, G., Fitzpatrick, D. J., Oliviero, G., Scelfo, A., Moran, B., Das, S., Munawar, N., Watson, A., Wynne, K. J., Negri, G. L., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696307 · Cited by 49
Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking
Sixto‐López, Y., Bello, M., & Correa‐Basurto, J. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1441072 · Cited by 49
Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1)
Cabezas, F., Farfán, P., & Marzolo, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213127 · Cited by 48
Role of the BAHD1 Chromatin-Repressive Complex in Placental Development and Regulation of Steroid Metabolism
Lakisic, G., Lebreton, A., Pourpre, R., Wendling, O., Libertini, E., Radford, E. J., Guillou, M. L., Champy, M., Wattenhofer‐Donzé, M., Soubigou, G., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005898 · Cited by 48
HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin
Romani, B., Jamil, R. K., Hamidi-Fard, M., Rahimi, P., Momen, S. B., Aghasadeghi, M. R., & Allahbakhshi, E. (2016) · Scientific Reports · doi:10.1038/srep31924 · Cited by 51
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2
Sharma, S., Poetz, F., Bruer, M., Ly-Hartig, T. B. N., Schott, J., Séraphin, B., & Stoecklin, G. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.030 · Cited by 48
Non-redundant functions of H2A.Z.1 and H2A.Z.2 in chromosome segregation and cell cycle progression
Gil, R. S., de Castro, I. J., Amin, H. A., Spanos, C., Vinciotti, V., Rappsilber, J., Sisu, C., & Vagnarelli, P. (2021) · EMBO Reports · doi:10.15252/embr.202052061 · Cited by 47
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
Smalley, J. P., Cowley, S. M., & Hodgkinson, J. T. (2020) · Molecules · doi:10.3390/molecules25194394 · Cited by 48
Self-citation
Sumoylation of HDAC2 promotes NF-κB-dependent gene expression
Wagner, T., Kiweler, N., Wolff, K., Knauer, S. K., Brandl, A., Hemmerich, P. H., Dannenberg, J., Heinzel, T., Schneider, G., & Krämer, O. H. (2015) · Oncotarget · doi:10.18632/oncotarget.3344 · Cited by 46
Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines
Abbas, A., Hall, J. A., Patterson, W. L., Ho, E., Hsu, A., Al‐Mulla, F., & Georgel, P. T. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0038 · Cited by 46
Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors
Chen, C., Hou, X., Wang, G., Pan, W., Yang, X., Zhang, Y., & Fang, H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.064 · Cited by 46
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
Sullivan, C. R., Mielnik, C. A., O'Donovan, S. M., Funk, A. J., Bentea, E., DePasquale, E. A. K., Alganem, K., Wen, Z., Haroutunian, V. H., Katsel, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1390-4 · Cited by 48
Integrative Modeling of a Sin3/HDAC Complex Sub-structure
Banks, C. A. S., Zhang, Y., Miah, S., Hao, Y., Adams, M. K., Wen, Z., Thornton, J. L., Florens, L. A., & Washburn, M. P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.080 · Cited by 46
An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives
Su, M., Gong, X.-Y., & Liu, F. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1877656 · Cited by 46
HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation
Nalawansha, D. A., Gomes, I. D., Wambua, M. K., & Pflum, M. K. H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.03.008 · Cited by 44
Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells
Enssle, J. C., Boedicker, C., Wanior, M., Vogler, M., Knapp, S., & Fulda, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.032 · Cited by 44
Role of HDAC inhibitors in diabetes mellitus
Makkar, R., Behl, T., & Arora, S. (2019) · Current Research in Translational Medicine · doi:10.1016/j.retram.2019.08.001 · Cited by 43
Histone Deacetylase 1 Is Essential for Rod Photoreceptor Differentiation by Regulating Acetylation at Histone H3 Lysine 9 and Histone H4 Lysine 12 in the Mouse Retina
Ferreira, R. C., Popova, E. Y., James, J., Briones, M. R. S., Zhang, S. S.-M., & Barnstable, C. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756643 · Cited by 41
HDAC1 and HDAC2 Modulate TGF-β Signaling during Endothelial-to-Hematopoietic Transition
Thambyrajah, R., Fadlullah, M. Z. H., Proffitt, M., Patel, R., Cowley, S. M., Kouskoff, V., & Lacaud, G. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.011 · Cited by 41
Self-citation
Bridging Synaptic and Epigenetic Maintenance Mechanisms of the Engram
Kyrke‐Smith, M., & Williams, J. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00369 · Cited by 43
Flow-induced HDAC1 phosphorylation and nuclear export in angiogenic sprouting
Bazou, D., Ng, M. R., Song, J. W., Chin, S. M., Maimon, N., & Munn, L. L. (2016) · Scientific Reports · doi:10.1038/srep34046 · Cited by 39
BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo
Liu, S., Li, F., Pan, L., Yang, Z., Shu, Y., Lv, W., Dong, P., & Gong, W. (2019) · Cancer Science · doi:10.1111/cas.14102 · Cited by 38

Authors: Kelly, R. D. W., & Cowley, S. M.
Affiliations: University of Leicester (GB)
ORCID: Kelly, Richard D.W.
Cowley, Shaun M.
Venue: Biochemical Society Transactions
Publisher: Portland Press Ltd.
Published: 2013-05-23
Volume: 41
Issue: 3
Pages: 741-749
ISSN: 0300-5127 (ISSN-L)
1470-8752
DOI: 10.1042/bst20130010
OpenAlex: W2071962829
Semantic Scholar: 21f432d2cd250d2a585a0680be5b15f6db12576d
Cited by: 297
References: 71
Citations by year: 2026: 3 · 2025: 16 · 2024: 20 · 2023: 22 · 2022: 22 · 2021: 33 · 2020: 23 · 2019: 24 · 2018: 33 · 2017: 22 · 2016: 32 · 2015: 23 · 2014: 21 · 2013: 3
FWCI: 2.48
Type: journal article
Language: en
Open access: closed
Locations: Biochemical Society Transactions (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council (MR/J009202/1)
Biotechnology and Biological Sciences Research Council (BB/J009598/1)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords: HDAC1, HDAC2, NuRD complex, CoREST complex, chromatin regulation, transcriptional repression, transcriptional activation, cell proliferation, histone deacetylase inhibitors, cancer drug targets
MeSH terms: Acetylation, Animals, Histones, Humans, Models, Biological, Transcription Factors, Signal Transduction, Mice, Knockout, Multiprotein Complexes, Mice, Histone Deacetylase 1, Histone Deacetylase 2, Co-Repressor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks